Where I see patients (1)
My reviews
Selected research
-
Multiomic single cell sequencing identifies stemlike nature of mixed phenotype acute leukemia.
Nature communications
-
Impact of Prior Inotuzumab Ozogamicin Treatment on Brexucabtagene Autoleucel outcomes in Adults with B-cell ALL.
Blood advances
-
Measurable residual disease conversion rate with consolidation chemotherapy in acute myeloid leukemia.
Leukemia & lymphoma
Clinical trials
Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis ...
The proportion of responder (complete response (CR) or partial response (PR)) or non-responder at the end of induction using a physician developed response criteria will be reported. Those with non-malignant HLH (nmHLH) will be as...
Recruiting
Contact me
- Request appointment
- Refer a patient
- (415) 353-2421
4.9